Hybrid~4 wks to decision Source verified 2026-11-05
Annals of the Rheumatic Diseases
Published by EULAR / Elsevier
Official EULAR journal publishing clinical trials and translational immunology in rheumatoid arthritis, lupus, vasculitis, spondyloarthritis, and osteoarthritis.
Core Submission Checklist & Author Requirements
- Structured abstract (Objectives, Methods, Results, Conclusions) and Key Messages box
- Patient and Public Involvement statement
Submission Requirements by Article Type
Original Research Specifications
Main manuscript text excluding references and supplementary material.
Main Text Limit
3,500 words
Abstract Cap
250 words
Displays (Figures & Tables)
Max 6
Peer Review Model
Single-blind
Reporting Guidelines
Ensure manuscript adheres to the appropriate EQUATOR Network guideline.
AI Writing & Image Policy
Authors must disclose the use of generative AI tools in the Methods or Acknowledgments. AI cannot be credited as an author; humans retain full accountability.
Figure policy: Human review mandatory
Publishing Fees / APC: No submission fee; hybrid open access option available
Data verified from official publisher guidelines at https://ard.bmj.com/pages/authors